We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.89B
AUM Growth
+$1B
Cap. Flow
+$522M
Cap. Flow %
18.04%
Top 10 Hldgs %
47.96%
Holding
234
New
67
Increased
34
Reduced
17
Closed
35

Sector Composition

Rank Sector Weight
1 Financials 13.19%
2 Consumer Discretionary 12.8%
3 Healthcare 12.62%
4 Communication Services 6.86%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWAC
101
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$2.99M 0.1%
300,000
GLAQ
102
DELISTED
Globis Acquisition Corp. common stock
GLAQ
$2.98M 0.1%
300,000
CAHC
103
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
$2.96M 0.1%
+300,000
New +$2.97M
MTA
104
Metalla Royalty & Streaming
MTA
$688M
$2.96M 0.1%
+342,665
New +$3.33M
DNZ
105
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.91M 0.1%
+300,000
New +$2.94M
CFRX
106
DELISTED
ContraFect Corporation
CFRX
$2.91M 0.1%
8,265
+2,640
+47% +$864K
QS icon
107
QuantumScape Corp
QS
$3.21B
$2.9M 0.1%
+99,170
New +$3.21M
NAUT icon
108
Nautilus Biotechnolgy
NAUT
$124M
$2.7M 0.09%
267,454
GSAT icon
109
Globalstar
GSAT
$10.7B
$2.58M 0.09%
96,572
YARW
110
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$2.58M 0.09%
+815
New +$3.23M
BTTX
111
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$2.57M 0.09%
+259,270
New +$2.58M
LRMR icon
112
Larimar Therapeutics
LRMR
$397M
$2.52M 0.09%
256,620
+36,484
+17% +$412K
PRVB
113
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.52M 0.09%
298,429
-331,571
-53% -$2.68M
DDMX
114
DELISTED
DD3 Acquisition Corp. II Class A Common Stock
DDMX
$2.48M 0.09%
250,000
COVA
115
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$2.42M 0.08%
+250,000
New +$2.43M
WGS icon
116
GeneDx Holdings
WGS
$1.93B
$2.41M 0.08%
5,222
BTMD icon
117
Biote Corp
BTMD
$68.2M
$2.31M 0.08%
+238,568
New +$2.34M
LKFT
118
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$2.3M 0.08%
+33,323
New +$2.54M
NUVB icon
119
Nuvation Bio
NUVB
$2.2B
$2.29M 0.08%
246,417
-353,583
-59% -$4.03M
PSTH
120
CALL
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$2.28M 0.08%
100,000
NUVB.WS
121
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$2.15M 0.07%
825,323
SAII
122
DELISTED
Software Acquisition Group Inc. II Class A Common Stock
SAII
$2.03M 0.07%
+204,114
New +$2.04M
ORIAU
123
DELISTED
Orion Biotech Opportunities Corp. Units
ORIAU
$2.01M 0.07%
+200,000
New +$2.02M
ACET icon
124
Adicet Bio
ACET
$85.2M
$2.01M 0.07%
+12,193
New +$2.48M
LEGO
125
DELISTED
Legato Merger Corp. Common stock
LEGO
$2M 0.07%
+200,000
New +$1.97M

Similar funds

683 Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, 683 Capital Management held 234 positions worth $2.89B, up 53% from $1.89B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

683 Capital Management deployed $522M of net new capital in Q2 2021, opening 67 new positions and adding to 34 existing holdings. Its largest new stake was TWC Tech Holdings II Corp. Class A Common Stock: 3,756,134 shares worth $37.3M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was People Inc, an estimated $32.9M trimmed.

  • 683 Capital Management's largest Q2 2021 buy was TWC Tech Holdings II Corp. Class A Common Stock: 3,756,134 shares worth $37.3M.
  • 683 Capital Management added most to Cardlytics in Q2 2021, an estimated $59.9M increase.
  • 683 Capital Management's biggest Q2 2021 reduction was People Inc, cutting an estimated $32.9M.
  • 683 Capital Management fully exited Mudrick Capital Acquisition Corporation II Class A Common Stock in Q2 2021, selling an estimated $19.6M.
  • 683 Capital Management's ten largest holdings make up 48% of its $2.89B portfolio in Q2 2021.
  • 683 Capital Management opened 67 new positions and closed 35 in Q2 2021.
  • 683 Capital Management's portfolio value rose 53% quarter-over-quarter to $2.89B.

Based on 683 Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.